Report: Investment in social media analytics software and services growing rapidly

Monday, September 10, 2012 03:06 PM

IDC Health Insights released a new IDC MarketScape report which helps end users evaluate the top nine leading social media analytics software and service vendors that currently address the pharmaceutical industry.

The comprehensive study, “IDC MarketScape: Worldwide Pharmaceutical Social Media Analytics 2012 Vendor Assessment,” shows the increasing interest in these software applications and profiles the following vendors: Brandwatch, Cognizant, Genpact Social and Digital Transformation Services, Indegene, ListenLogic, Meltwater, Radian6, Semantelli and Visible Technologies.

The IDC Health Insights research found that while spending on outbound social media marketing is lagging, investment in social media analytics software and services is growing rapidly and expected to increase significantly for the next several years. Pharmaceutical companies are seeking new ways to measure brand perception, keep tabs on end-consumer sentiment around products and therapeutic categories, and gain insight into competing brand strategy, pricing, promotions and other relevant competitive information. As such, companies are looking for vendors with industry-specific expertise, strong customer references, and proven experience delivering measured value to pharmaceutical organizations.

"The pharmaceutical industry has been slow to embrace social media marketing, largely due to the lack of guidance currently available from the FDA. Uncertainty around proper procedure, coupled with potential liability related to tracking adverse events reported in social media settings, is keeping pharmas from utilizing this marketing channel as much as desired," said Eric Newmark, program director, IDC Health Insights. "Despite those challenges we have received an increasing number of client inquiries on social media analytics as pharmaceutical companies realize the potential impact social media channels can have on brand perception and marketing execution."

IDC MarketScape criteria selection, weightings and vendor scores represent well-researched IDC judgment about the market and specific vendors.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs